Adenovirus Based Virotherapy Market Players:
- Amgen Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Merck & Co., Inc.
- Novartis International AG
- Johnson & Johnson
- Genelux Corporation
- PsiOxus Therapeutics
- Oncorus, Inc.
- SillaJen, Inc.
- Transgene SA
- Virttu Biologics Limited
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of adenovirus based virotherapy is estimated at USD 15.26 billion.
The global adenovirus based virotherapy market size was around USD 14.5 billion in 2025 and is likely to expand at a CAGR of more than 5.8%, surpassing USD 25.48 billion revenue by 2035.
Key players in the market include Amgen Inc., Merck & Co., Inc., Novartis International AG, Johnson & Johnson, Genelux Corporation, PsiOxus Therapeutics, Oncorus, Inc.
